Amgen (AMGN) Tops Q4 EPS by 27c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $410.24 +4.34%
EPS Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +2.7%
Financial Fact:
Product sales: 5.52B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.31, $0.27 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.1 billion versus the consensus estimate of $8.85 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.82.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Clean Air Metals closes C$6.2M private placement tied to Springbok deal
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
